Page last updated: 2024-10-21

chlorocresol and Diathesis

chlorocresol has been researched along with Diathesis in 8 studies

chlorocresol: injections for relief of intractable pain; RN given refers to parent cpd
4-chloro-m-cresol : A hydroxytoluene that is 3-methylphenol which is substituted by a chlorine at position 4. A ryanodine receptor agonist.

Research Excerpts

ExcerptRelevanceReference
" MHEh muscles revealed a dose-response curve similar to that found in MHN specimens."1.30Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol. ( Bittner, RE; Fricker, R; Gilly, H; Kress, HG; Musat, I; Steinbereithner, K, 1997)
"Chlorocresol was demonstrated to be a potent activator of Ca++ release from skeletal muscle sarcoplasmic reticulum."1.30[Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients]. ( Adnet, PJ; Ben-Abraham, R; Haudcoeur, G; Krivosic-Horber, RM; Perel, A, 1997)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (50.00)18.2507
2000's4 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, PD1
López, JR1
Sei, Y1
Brandom, BW1
Bina, S1
Hosoi, E1
Gallagher, KL1
Wyre, HW1
Pudimat, PA1
Holman, SJ1
Venzon, DJ1
Daly, JW1
Muldoon, S1
Klingler, W2
Baur, C1
Georgieff, M1
Lehmann-Horn, F2
Melzer, W1
Wappler, F1
Anetseder, M1
Baur, CP1
Censier, K1
Doetsch, S1
Felleiter, P1
Fiege, M1
Fricker, R2
Halsall, PJ1
Hartung, E1
Heffron, JJ1
Heytens, L1
Hopkins, PM1
Nivoche, Y1
Tegazzin, V1
Tzanova, I1
Urwyler, A1
Weisshorn, R1
Schulte am Esch, J1
Gilly, H1
Musat, I1
Bittner, RE1
Steinbereithner, K1
Kress, HG1
Ben-Abraham, R1
Krivosic-Horber, RM1
Haudcoeur, G1
Perel, A1
Adnet, PJ1
Gronert, GA1
Ording, H1
Glahn, K1
Gardi, T1
Fagerlund, T1
Bendixen, D1

Trials

1 trial available for chlorocresol and Diathesis

ArticleYear
Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
    European journal of anaesthesiology, 2003, Volume: 20, Issue:7

    Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques; Malignant

2003

Other Studies

7 other studies available for chlorocresol and Diathesis

ArticleYear
"Noninvasive" testing for malignant hyperthermia susceptibility.
    Anesthesiology, 2002, Volume: 97, Issue:5

    Topics: Caffeine; Calcium; Cresols; Disease Susceptibility; Halothane; Humans; Malignant Hyperthermia; Muscl

2002
Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
    Anesthesiology, 2002, Volume: 97, Issue:5

    Topics: Adolescent; Adult; B-Lymphocytes; Caffeine; Calcium; Child; Cresols; Disease Susceptibility; Halotha

2002
Detection of proton release from cultured human myotubes to identify malignant hyperthermia susceptibility.
    Anesthesiology, 2002, Volume: 97, Issue:5

    Topics: Calcium; Cells, Cultured; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Humans;

2002
Classification of malignant hyperthermia-equivocal patients by 4-chloro-M-cresol.
    Anesthesia and analgesia, 1997, Volume: 85, Issue:1

    Topics: Adolescent; Adult; Aged; Anesthetics, Inhalation; Caffeine; Cresols; Disease Susceptibility; Dose-Re

1997
[Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Harefuah, 1997, Jun-15, Volume: 132, Issue:12

    Topics: Adolescent; Adult; Caffeine; Cresols; Disease Susceptibility; Halothane; Humans; In Vitro Techniques

1997
Testing for MH susceptibility.
    Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:8

    Topics: Cresols; Disease Susceptibility; Genetic Markers; Humans; Malignant Hyperthermia; Muscle Contraction

1997
4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Acta anaesthesiologica Scandinavica, 1997, Volume: 41, Issue:8

    Topics: Biopsy; Caffeine; Cresols; Disease Susceptibility; Dose-Response Relationship, Drug; Halothane; Huma

1997